0001209191-21-021160.txt : 20210316 0001209191-21-021160.hdr.sgml : 20210316 20210316194357 ACCESSION NUMBER: 0001209191-21-021160 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210312 FILED AS OF DATE: 20210316 DATE AS OF CHANGE: 20210316 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jayaraman Vivek K CENTRAL INDEX KEY: 0001605456 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21937 FILM NUMBER: 21747861 MAIL ADDRESS: STREET 1: 3910 BRICKWAY BLVD CITY: SANTA ROSA STATE: CA ZIP: 95403 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CERUS CORP CENTRAL INDEX KEY: 0001020214 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 680262011 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1220 CONCORD AVENUE STREET 2: SUITE 600 CITY: CONCORD STATE: CA ZIP: 94520 BUSINESS PHONE: 9252886000 MAIL ADDRESS: STREET 1: 1220 CONCORD AVENUE STREET 2: SUITE 600 CITY: CONCORD STATE: CA ZIP: 94520 FORMER COMPANY: FORMER CONFORMED NAME: CERUS TECHNOLOGIES INC DATE OF NAME CHANGE: 19960731 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-03-12 0 0001020214 CERUS CORP CERS 0001605456 Jayaraman Vivek K C/O CERUS CORPORATION 1220 CONCORD AVE SUITE 600 CONCORD CA 94520 0 1 0 0 Chief Operating Officer Common Stock 2021-03-12 4 M 0 15833 A 153888 D Common Stock 2021-03-15 4 S 0 5556 6.3777 D 148332 D Common Stock 2021-03-12 4 M 0 45000 A 193332 D Common Stock 2021-03-15 4 S 0 15786 6.3777 D 177546 D Common Stock 2021-03-12 4 M 0 42900 A 220446 D Common Stock 2021-03-15 4 S 0 15807 6.3777 D 204639 D Restricted Stock Unit 2021-03-12 4 M 0 15833 D Common Stock 15833 0 D Restricted Stock Unit 2021-03-12 4 M 0 45000 D Common Stock 45000 45000 D Restricted Stock Unit 2021-03-12 4 M 0 42900 D Common Stock 42900 87100 D Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Includes 3,052 shares purchased under Issuer's Employee Stock Purchase Plan on 02/28/21. Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person. The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.285 to $6.445 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. The restricted stock unit vests in three equal annual installments beginning on March 12, 2019. Not applicable. The restricted stock unit vests in three equal annual installments beginning on March 12, 2020. The restricted stock unit vests in three equal annual installments beginning on March 12, 2021. Vivek K. Jayaraman, by Chrystal Menard, attorney-in-fact 2021-03-16